AI MARKET SCANNING

Pliant Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +1.41%
MAX GAP RECORD +10.00%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PLRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
+0.97%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
+0.00%
Mar 11, 2026 Earnings Release 2026-03-11 (AFTER CLOSE)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-1.31%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-7.14%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+0.70%
Mar 03, 2025 Earnings Release 2025-03-03 (AFTER CLOSE)
+4.35%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
+0.13%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.8%
Bullish Gaps (6)
Bearish Gaps (2)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PLRX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-12 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1068m +11.14%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes,…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗